Graham Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,506
| Closed | -$1.07M | – | 1450 |
|
|
2024
Q4 | $1.07M | Buy |
+1,506
| New | +$1.07M | 0.02% | 451 |
|
|
2024
Q3 | – | Sell |
-389
| Closed | -$409K | – | 1272 |
|
|
2024
Q2 | $409K | Sell |
389
-1,149
| -75% | -$1.21M | 0.01% | 619 |
|
|
2024
Q1 | $1.48M | Sell |
1,538
-402
| -21% | -$387K | 0.03% | 289 |
|
|
2023
Q4 | $1.7M | Buy |
+1,940
| New | +$1.7M | 0.04% | 220 |
|
|
2023
Q3 | – | Sell |
-864
| Closed | -$621K | – | 1235 |
|
|
2023
Q2 | $621K | Buy |
+864
| New | +$621K | 0.02% | 485 |
|
|
2022
Q3 | – | Sell |
-3,128
| Closed | -$1.85M | – | 1270 |
|
|
2022
Q2 | $1.85M | Buy |
+3,128
| New | +$1.85M | 0.07% | 221 |
|